Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karl Coutinho, MD
New Jersey Urology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Urology
Little Rock, Arkansas, United States
Recruiting - Orlando Health
Orlando, Florida, United States
Recruiting - Florida Urology
Tampa, Florida, United States
Recruiting - Regional Urology
Shreveport, Louisiana, United States
Completed - Chesapeake
Hanover, Maryland, United States
Completed - Freedman Urology
Las Vegas, Nevada, United States
Recruiting - New Jersey Urolgy
Millburn, New Jersey, United States
Completed - Western New York
Cheektowaga, New York, United States
Recruiting - Urology Clinics of North Texas
Dallas, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Feb 2022
- Primary completion
- 30 Jun 2026
- Completion
- 30 Dec 2026
- Last update posted
- 28 Apr 2026
- Registered enrollment
- 34
- Registry id
- NCT05383274
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.